NDAORALTABLET, EXTENDED RELEASE
Approved
Sep 2002
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Mechanism of Action
12.1 Mechanism of Action Amoxicillin and Clavulanate Potassium Extended Release Tablets is an antibacterial drug [see Clinical Pharmacology ] . 12.3 Pharmacokinetics Amoxicillin and Clavulanate Potassium Extended Release Tablets is an extended-release formulation which provides sustained plasma…
Indications (13)
infections due to Sequal to 40 kgacute bacterial sinusitis due to confirmedsuspected beta-lactamase-producing pathogens (idevelopment of drug-resistant bacteriamaintain the effectiveness of AmoxicillinClavulanate Potassium Extended Release Tabletsother antibacterial drugsAmoxicillinClavulanate Potassium Extended Release Tablets should be used only to treatprevent infectionsstrongly suspected to be caused by susceptible bacteriastrongly suspected to be caused by bacteria